Stay updated on CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial
Sign up to get notified when there's something new on the CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial page.

Latest updates to the CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision label updated: added Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision: v3.3.3 is now displayed in the footer, and the previous Revision: v3.3.2 and the HHS Vulnerability Disclosure link were removed.SummaryDifference0.1%

- Check59 days agoChange DetectedRevision tag updated from v3.2.0 to v3.3.2 on the page. This is a backend versioning update and does not alter the displayed study information or user-facing features.SummaryDifference0.0%

- Check67 days agoChange DetectedThe page no longer displays the government funding lapse notice related to NIH operations, affecting only an operational banner rather than the study content. No other study information appears to be changed.SummaryDifference0.3%

- Check81 days agoChange DetectedPosted study results for NCT02325219, with primary/secondary outcomes and QC dates now visible alongside the results timeline. Enrollment, completion dates, and locations have also been updated.SummaryDifference0.3%

- Check110 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference1%

Stay in the know with updates to CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CNTO 1959 Efficacy & Safety in Psoriasis: Clinical Trial page.